Jilted Akorn sues Fresenius over deal termination

FRANKFURT (Reuters) - U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news